The U.S. Food and Drug Administration (FDA) has cleared advanced visualization and AI software developer Coreline Soft's AI-based radiotherapy autocontouring system, AView RT ACS.
The system provides deep learning-based autosegmentation of organs on CT and generates head and neck, breast, abdomen, and pelvis contouring in an RT-DICOM format, the company said.
